Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Renal Transplant Recipients (OPTI-TREX)

Condition:   Patients Included Are Pediatric Renal Transplant Recipients With an Indication for Enoxaparin Treatment in the First Post-transplant Week Interventions:   Drug: Bayesian based dose adjustment of enoxaparin;   Drug: Usual dose adjustment of enoxaparin Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials